Abstract
On 20 January 2020, the Court of Justice of the European Union (CJEU) handed down its ruling in Case C-307/18 Generics (UK) and Others on ten complex questions referred by the UK Competition Appeal Tribunal (CAT) in the context of an appeal against a decision of the UK Competition and Markets Authority (CMA). In what will probably come to be regarded as a landmark judgment in EU competition law, the CJEU ruled for the first time on settlement agreements between originator pharmaceutical companies and producers of generic medicines
Original language | English |
---|---|
Pages (from-to) | 150-163 |
Number of pages | 14 |
Journal | European Competition and Regulatory Law Review |
Volume | 4 |
Issue number | 2 |
Early online date | 31 May 2020 |
DOIs | |
Publication status | Published - 2020 |
Keywords
- European Union
- EU Competition Law